以科學見解探討果寡糖 (FOS) 健康訴求的科學背景。

依第 1924/2006 號法案 (EC) 第 13 (1) 條，確立果寡糖 (FOS, fructo-oligosaccharides) 健康功效訴求的相關科學見解，包括降低胃腸道致病微生物 (ID 774)、改變短鍊脂肪酸 (SCFA) 生成與腸胃道 pH 值 (ID 775)、胃腸道功能變化 (ID 775, 778)、降低胃腸不適 (ID 775, 778)、增加鈣或鎂吸收進而增加鎂或鈣保留量 (ID 776, 777)、維持正常 LDL-膽固醇血中濃度 (ID 805)、維持正常 (空腹) 三酸甘油酯血中濃度 (ID 805)。

參考資料

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to fructooligosaccharides (FOS) from sucrose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 774), changes in short chain fatty acid (SCFA) production and pH in the gastrointestinal tract (ID 775), changes in bowel function (ID 775, 778), reduction of gastrointestinal discomfort (ID 775, 778), increase in calcium and/or magnesium absorption leading to an increase in magnesium and/or calcium retention (ID 776, 777), maintenance of normal blood LDL-cholesterol concentrations (ID 805) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 805) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2023. [25 pp.]. doi:10.2903/j.efsa.2011.2023.